loceryl has been researched along with Dermatomycoses in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 15 (71.43) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Tan, J; Yang, L; Zhang, J | 1 |
| Tsunemi, Y | 1 |
| Fothergill, AW; McCarthy, DI; Tavakkol, A; Wiederhold, NP | 1 |
| Galhardo, MC; Oliveira, LA; Reis, RS; Valle, AC; Wanke, B | 1 |
| Li, M; Li, RY; Liu, WD; Lu, CM; Shen, YN; Wan, Z; Wang, AP; Xi, LY; Zeng, FQ | 1 |
| Gupta, AK; Sauder, DN; Shear, NH | 1 |
| Bergstraesser, M; Nolting, S; Reckers-Czaschka, R; Reinel, D; Semig, G; Zaug, M | 1 |
| Bryson, HM; Haria, M | 1 |
| DeDoncker, PR; Degreef, HJ | 1 |
| Rosenthal, SA; Shupack, JL; Stiller, MJ | 1 |
| Agarwal, A; Singh, SM | 1 |
| Hernanz Hermosa, JM; Lázaro Ochaita, P | 1 |
| Bergstraesser, M; del Palacio, A; Gip, L; Zaug, M | 1 |
| Bergstraesser, M; Dietz, M; Friedrich, HK; Nolting, S; Reckers-Czaschka, R; Semig, G; Zaug, M | 1 |
| Bergstraesser, M; Zaug, M | 1 |
| Cuétara, S; del Palacio, A; García-Bravo, M; Iglesias-Diez, L; López-Gómez, S; Rodriguez-Noriega, A | 1 |
| Polak, A | 1 |
| Aoki, K; Uchida, K; Yamaguchi, H | 1 |
| Uchida, K; Yamaguchi, H | 1 |
| Matsuzaka, A; Uchida, K; Yamaguchi, H | 1 |
| del Palacio-Hernanz, A; González-Lastra, F; López-Gómez, S; Moreno-Palancar, P | 1 |
6 review(s) available for loceryl and Dermatomycoses
| Article | Year |
|---|---|
Antifungal agents: an overview. Part II.
Topics: Allylamine; Antifungal Agents; Azoles; Dermatomycoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine | 1994 |
Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Dermatomycoses; Female; Humans; Microbial Sensitivity Tests; Morpholines; Onychomycosis | 1995 |
Current therapy of dermatophytosis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Time Factors; Tolnaftate | 1994 |
Treatment of dermatophytoses II: Newer topical antifungal drugs.
Topics: Allylamine; Antifungal Agents; Chemical Phenomena; Chemistry; Dermatomycoses; Humans; Imidazoles; Morpholines | 1993 |
A case of cutaneous phaeohyphomycosis caused by Exserohilum rostratum, its in vitro sensitivity and review of literature.
Topics: Adult; Antifungal Agents; Child; Dermatomycoses; Female; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Mitosporic Fungi; Morpholines | 1995 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles | 1995 |
6 trial(s) available for loceryl and Dermatomycoses
| Article | Year |
|---|---|
Amorolfine spray in the treatment of foot mycoses (a dose-finding study).
Topics: Adult; Aerosols; Antifungal Agents; Candidiasis; Dermatomycoses; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Morpholines; Ointments; Safety; Sensation Disorders; Skin Diseases; Tinea Pedis | 1993 |
Dose-finding study of amorolfine cream (0.125%, 0.25% and 0.5%) in the treatment of dermatomycoses.
Topics: Administration, Topical; Antifungal Agents; Dermatomycoses; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Morpholines; Ointments; Random Allocation; Treatment Outcome | 1992 |
Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses.
Topics: Antifungal Agents; Dermatomycoses; Double-Blind Method; Female; Humans; Imidazoles; Male; Morpholines; Treatment Outcome | 1992 |
Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Dermatomycoses; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Onychomycosis; Random Allocation; Treatment Outcome | 1992 |
Experience with amorolfine in the treatment of dermatomycoses.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Dermatomycoses; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Morpholines | 1992 |
A clinical double-blind trial comparing amorolfine cream 0.5% (RO-14-4767) with bifonazole cream 1% in the treatment of dermatomycoses.
Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatomycoses; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Morpholines; Randomized Controlled Trials as Topic | 1989 |
9 other study(ies) available for loceryl and Dermatomycoses
| Article | Year |
|---|---|
Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Synergism; Humans; Imidazoles; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Morpholines; Species Specificity; Tacrolimus; Terbinafine; Triamcinolone Acetonide | 2018 |
[Photo quiz: Dermatomycosis].
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Dermatomycoses; Fungi; Humans; Morpholines; Ointments; Skin | 2013 |
Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dermatomycoses; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2014 |
Disseminated dermatophytosis caused by Microsporum gypseum in an AIDS patient: response to terbinafine and amorolfine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Dermatomycoses; Humans; Male; Microsporum; Morpholines; Naphthalenes; Terbinafine; Treatment Outcome | 2004 |
In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
Topics: Anti-Infective Agents, Local; Antifungal Agents; Candida; China; Dermatomycoses; Drug Evaluation, Preclinical; Fungi; Humans; Microbial Sensitivity Tests; Morpholines; Trichophyton | 2004 |
Preclinical data and mode of action of amorolfine.
Topics: Animals; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Dermatomycoses; Disease Models, Animal; Female; Guinea Pigs; Humans; Mice; Morpholines; Sterols; Tinea | 1992 |
[In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis].
Topics: Antifungal Agents; Clotrimazole; Dermatomycoses; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines | 1991 |
[Retention of amorolfine in the skin tissue as measured by prevention of the development of experimental dermatophytosis in guinea pigs].
Topics: Animals; Antifungal Agents; Dermatomycoses; Female; Guinea Pigs; Imidazoles; Morpholines; Trichophyton | 1991 |
[Therapeutic effect of amorolfine on experimental dermatophytosis].
Topics: Animals; Antifungal Agents; Dermatomycoses; Female; Guinea Pigs; Imidazoles; Morpholines; Trichophyton | 1991 |